| Primary |
| Meningitis |
26.2% |
| Cystic Fibrosis |
8.2% |
| Urinary Tract Infection |
8.2% |
| Pseudomonas Infection |
6.6% |
| Urinary Tract Infection Pseudomonal |
6.6% |
| Prostatitis |
4.9% |
| Sepsis |
4.9% |
| Groin Abscess |
3.3% |
| Infection |
3.3% |
| Lung Disorder |
3.3% |
| Nosocomial Infection |
3.3% |
| Osteomyelitis |
3.3% |
| Pneumonia |
3.3% |
| Pyelonephritis |
3.3% |
| Respiratory Disorder |
3.3% |
| Abdominal Abscess |
1.6% |
| Bronchiectasis |
1.6% |
| Gram Stain Negative |
1.6% |
| Otitis Externa |
1.6% |
| Pain |
1.6% |
|
| Death |
12.5% |
| Rash |
9.4% |
| Toxic Epidermal Necrolysis |
9.4% |
| Arrhythmia |
6.3% |
| Expired Drug Administered |
6.3% |
| Myalgia |
6.3% |
| Pyrexia |
6.3% |
| Renal Failure Acute |
6.3% |
| Adverse Drug Reaction |
3.1% |
| Angioedema |
3.1% |
| Circumstance Or Information Capable Of Leading To Medication Error |
3.1% |
| Delirium |
3.1% |
| Dermatitis Exfoliative |
3.1% |
| Diplopia |
3.1% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.1% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
3.1% |
| Febrile Bone Marrow Aplasia |
3.1% |
| Hepatic Enzyme Increased |
3.1% |
| Hyperhidrosis |
3.1% |
| Hypophosphataemia |
3.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
11.5% |
| Product Used For Unknown Indication |
10.1% |
| Acute Generalised Exanthematous Pustulosis |
9.4% |
| Allogenic Bone Marrow Transplantation Therapy |
7.9% |
| Urinary Tract Infection |
7.2% |
| Pneumonia Aspiration |
6.5% |
| Meningitis Enterococcal |
5.0% |
| Candidiasis |
4.3% |
| Groin Abscess |
4.3% |
| Septic Shock |
4.3% |
| Abscess Limb |
3.6% |
| Febrile Neutropenia |
3.6% |
| Immunosuppressant Drug Therapy |
3.6% |
| Immunosuppression |
3.6% |
| Infection |
3.6% |
| Fungal Infection |
2.9% |
| Stem Cell Transplant |
2.9% |
| Ill-defined Disorder |
2.2% |
| Trichosporon Infection |
2.2% |
| Acute Myeloid Leukaemia |
1.4% |
|
| Rash |
8.8% |
| Trichosporon Infection |
8.8% |
| Hepatocellular Injury |
5.9% |
| Hypothermia |
5.9% |
| Lactic Acidosis |
5.9% |
| Neutropenia |
5.9% |
| Renal Failure |
5.9% |
| Toxic Epidermal Necrolysis |
5.9% |
| Toxic Skin Eruption |
5.9% |
| Urinary Tract Infection |
5.9% |
| Vascular Purpura |
5.9% |
| White Blood Cell Count Decreased |
5.9% |
| Arrhythmia |
2.9% |
| Asthenia |
2.9% |
| Brain Stem Haemorrhage |
2.9% |
| Circulatory Collapse |
2.9% |
| Confusional State |
2.9% |
| Delirium |
2.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.9% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
16.7% |
| Prophylaxis |
13.2% |
| Drug Use For Unknown Indication |
11.8% |
| Infection |
9.0% |
| Pain |
4.8% |
| Pyrexia |
4.6% |
| Acute Lymphocytic Leukaemia |
3.9% |
| Hypertension |
3.6% |
| Constipation |
3.4% |
| Neoplasm Malignant |
3.4% |
| Pneumonia |
3.0% |
| Acute Myeloid Leukaemia |
2.9% |
| Chemotherapy |
2.9% |
| Fungal Infection |
2.9% |
| Acquired Immunodeficiency Syndrome |
2.6% |
| Anxiety |
2.5% |
| Sepsis |
2.3% |
| Aplastic Anaemia |
2.2% |
| Cancer Pain |
2.2% |
| Diabetes Mellitus |
2.2% |
|
| White Blood Cell Count Decreased |
9.3% |
| Pain |
8.1% |
| Respiratory Failure |
8.1% |
| Septic Shock |
7.0% |
| Renal Failure Acute |
5.8% |
| Thrombocytopenia |
5.8% |
| Toxic Skin Eruption |
5.8% |
| Weight Increased |
5.8% |
| Pericarditis |
4.7% |
| Pyrexia |
4.7% |
| Weight Decreased |
4.7% |
| Alanine Aminotransferase Increased |
3.5% |
| Death |
3.5% |
| Pancreatitis Acute |
3.5% |
| Pulmonary Embolism |
3.5% |
| Respiration Abnormal |
3.5% |
| Sepsis |
3.5% |
| Toxic Epidermal Necrolysis |
3.5% |
| Urosepsis |
3.5% |
| Aspartate Aminotransferase Increased |
2.3% |
|
